In Vitro and In Vivo Activities of SCH 56592 (Posaconazole), a New Triazole Antifungal Agent, against Aspergillus and Candida

SCH 56592 (posaconazole), a new triazole antifungal agent, was tested in vitro, and its activity was compared to that of itraconazole against 39 Aspergillus strains and to that of fluconazole against 275 Candida and 9 Cryptococcus strains. The SCH 56592 MICs for Aspergillus ranged from ≤0.002 to 0.5...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Cacciapuoti, Anthony, Loebenberg, David, Corcoran, Erik, Menzel, Fred, Moss, Eugene L., Norris, Christine, Michalski, Monika, Raynor, Kimberly, Halpern, Judith, Mendrick, Cara, Arnold, Brian, Antonacci, Barry, Parmegiani, Raulo, Yarosh-Tomaine, Taisa, Miller, George H., Hare, Roberta S.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2000
Assuntos:	Experimental Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90007/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10898669/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.8.2017-2022.2000
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!